Blood Cancer Journal

Welcome to Blood Cancer Journal

A peer-reviewed online open access journal seeking to publish articles of the highest quality related to hematologic malignancies and related disorders

Featured

The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review

Hira Mian
Arleigh McCurdy
Tanya M. Wildes
ArticleOpen Access05 Jan 2023
Multiple myeloma with acute light chain cast nephropathy

Nelson Leung
S. Vincent Rajkumar
Current Treatment AlgorithmOpen Access29 Mar 2023
Lymphoid clonal hematopoiesis: implications for malignancy, immunity, and treatment

Kelly von Beck
Troy von Beck
Ashwin Kishtagari
Review ArticleOpen Access04 Jan 2023
Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients

Rodrigo Fonseca
Mariano Arribas
Rafael Fonseca
ArticleOpen Access06 Mar 2023

Announcements

Current Treatment Algorithms

Blood Cancer Journal proudly publishes ‘Current Treatment Algorithms’, an article type dedicated to providing clear, authoritative, concise treatment pathways for hematologic malignancies. Read the full series here.
Featured article including author video summary

Management of belantamab mafodotin-associated corneal events in patients with relapsed or refractory multiple myeloma (RRMM) Listen to the authors of this article discussing their recommendations for the assessment and management of belamaf-associated ocular events to help mitigate ocular risk and enable patients to continue to experience a clinical benefit with belamaf.
Follow us on Twitter!

Join the Blood Cancer Journal Twitter Community
@BloodCancerJnl
Follow us to keep up-to-date with the latest research and news from Blood Cancer Journal. Share your views, retweet and give us feedback.

Browse articles

Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience

I. Vaxman
S. K. Kumar
A. Dispenzieri
CorrespondenceOpen Access31 May 2023
Exercise-induced release of cardiac and skeletal muscle injury biomarkers in patients with chronic myeloid leukemia receiving TKI therapy

Lando Janssen
Neeltje A. E. Allard
Maria T. E. Hopman
CorrespondenceOpen Access30 May 2023
Should I stay or should I go (to transplant)? Managing insufficient responses to induction in multiple myeloma

Rahul Banerjee
Louis Williams
Joseph R. Mikhael
EditorialOpen Access30 May 2023
UBTF tandem duplications are rare but recurrent alterations in adult AML and associated with younger age, myelodysplasia, and inferior outcome

Julia-Annabell Georgi
Sebastian Stasik
Christian Thiede
ArticleOpen Access26 May 2023
High SOX2 expression is associated with poor survival in patients with newly diagnosed multiple myeloma

Xinhe Shan
Qi Long
Sandra P. Susanibar-Adaniya
CorrespondenceOpen Access22 May 2023
Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myeloma

Linda B. Baughn
Erik Jessen
Shaji K. Kumar
ArticleOpen Access22 May 2023
A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients

A. Vera de Jonge
Erik van Werkhoven
Martine E. D. Chamuleau
ArticleOpen Access22 May 2023
Cardiac toxicities in multiple myeloma: an updated and a deeper look into the effect of different medications and novel therapies

Jean El-Cheikh
Nour Moukalled
Mohamad Mohty
Review ArticleOpen Access19 May 2023
Global burden of hematologic malignancies and evolution patterns over the past 30 years

Nan Zhang
Jinxian Wu
Fuling Zhou
ArticleOpen Access17 May 2023

A new year brings a new series for Blood Cancer Journal - January 2018 sees the launch of a new article type called ‘Current Treatment Algorithms’, a new series dedicated to providing clear, authoritative, concise treatment pathways for hematologic malignancies.

Collection 12 Jan 2018

Trending - Altmetric

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics.

Welcome to Blood Cancer Journal

Featured

The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review

Multiple myeloma with acute light chain cast nephropathy

Lymphoid clonal hematopoiesis: implications for malignancy, immunity, and treatment

Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients

Announcements

Current Treatment Algorithms

Featured article including author video summary

Follow us on Twitter!

Browse articles

Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience

Exercise-induced release of cardiac and skeletal muscle injury biomarkers in patients with chronic myeloid leukemia receiving TKI therapy

Should I stay or should I go (to transplant)? Managing insufficient responses to induction in multiple myeloma

UBTF tandem duplications are rare but recurrent alterations in adult AML and associated with younger age, myelodysplasia, and inferior outcome

High SOX2 expression is associated with poor survival in patients with newly diagnosed multiple myeloma

Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myeloma

A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients

Cardiac toxicities in multiple myeloma: an updated and a deeper look into the effect of different medications and novel therapies

Global burden of hematologic malignancies and evolution patterns over the past 30 years

Collections

Current Treatment Algorithms

Trending - Altmetric

Search

Quick links

Featured

Announcements

Advertisement

Trending - Altmetric

‘Acute myeloid leukemia: a comprehensive review and 2016 update’

Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors

Should I stay or should I go (to transplant)? Managing insufficient responses to induction in multiple myeloma

Global burden of hematologic malignancies and evolution patterns over the past 30 years

Search

Quick links